TY - JOUR
T1 - Baveno VII – Renewing consensus in portal hypertension
AU - Baveno VII Faculty
AU - de Franchis, Roberto
AU - Bosch, Jaime
AU - Garcia-Tsao, Guadalupe
AU - Reiberger, Thomas
AU - Ripoll, Cristina
AU - Abraldes, Juan G.
AU - Albillos, Agustin
AU - Baiges, Anna
AU - Bajaj, Jasmohan
AU - Bañares, Rafael
AU - Barrufet, Marta
AU - Benajiba, Lina
AU - Berzigotti, Annalisa
AU - Bureau, Christophe
AU - Calvaruso, Vincenza
AU - Cardenas, Andres
AU - D'Amico, Gennaro
AU - De Gottardi, Andrea
AU - Dell'Era, Alessandra
AU - Escorsell, Angels
AU - Fallowfield, Jonathan
AU - Ferral, Hector
AU - Francque, Sven
AU - Gaba, Ron
AU - Garcia-Pagàn, Juan Carlos
AU - Genescà, Joan
AU - Rodrigues, Susana Gomes
AU - Gracia-Sancho, Jordi
AU - Han, Guogong
AU - Hernandez-Gea, Virginia
AU - Jia, Jidong
AU - Kiladjian, Jean Jacques
AU - Krag, Aleksander
AU - Laleman, Wim
AU - La Mura, Vincenzo
AU - Lens, Sabela
AU - Luo, Xuefeng
AU - Mandorfer, Mattias
AU - Murad, Sarwa Darwish
AU - Paradis, Valerie
AU - Patch, David
AU - Piano, Salvatore
AU - Pinzani, Massimo
AU - Plessier, Aurelie
AU - Primignani, Massimo
AU - Procopet, Bogdan
AU - Rautou, Pierre Emmanuel
AU - Rudler, Marika
AU - Sarin, Shiv K.
AU - Shah, Vijay
N1 - Publisher Copyright:
© 2021 European Association for the Study of the Liver
PY - 2022/4
Y1 - 2022/4
N2 - To expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD – defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different diagnostic and therapeutic needs. Accordingly, the Baveno VII workshop was entitled “Personalized Care for Portal Hypertension”. The main fields of discussion were the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard, the use of non-invasive tools for the diagnosis of cACLD and CSPH, the impact of aetiological and non-aetiological therapies on the course of cirrhosis, the prevention of the first episode of decompensation, the management of an acute bleeding episode, the prevention of further decompensation, as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. For each of these 9 topics, a thorough review of the medical literature was performed, and a series of consensus statements/recommendations were discussed and agreed upon. A summary of the most important conclusions/recommendations derived from the workshop is reported here. The statements are classified as unchanged, changed, and new in relation to Baveno VI.
AB - To expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD – defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different diagnostic and therapeutic needs. Accordingly, the Baveno VII workshop was entitled “Personalized Care for Portal Hypertension”. The main fields of discussion were the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard, the use of non-invasive tools for the diagnosis of cACLD and CSPH, the impact of aetiological and non-aetiological therapies on the course of cirrhosis, the prevention of the first episode of decompensation, the management of an acute bleeding episode, the prevention of further decompensation, as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. For each of these 9 topics, a thorough review of the medical literature was performed, and a series of consensus statements/recommendations were discussed and agreed upon. A summary of the most important conclusions/recommendations derived from the workshop is reported here. The statements are classified as unchanged, changed, and new in relation to Baveno VI.
KW - Cirrhosis
KW - decompensation
KW - diagnosis
KW - recommendations
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85123913982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123913982&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2021.12.022
DO - 10.1016/j.jhep.2021.12.022
M3 - Review article
C2 - 35120736
AN - SCOPUS:85123913982
SN - 0168-8278
VL - 76
SP - 959
EP - 974
JO - Journal of hepatology
JF - Journal of hepatology
IS - 4
ER -